1. Home
  2. XNET vs RAPP Comparison

XNET vs RAPP Comparison

Compare XNET & RAPP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XNET
  • RAPP
  • Stock Information
  • Founded
  • XNET 2003
  • RAPP 2022
  • Country
  • XNET China
  • RAPP United States
  • Employees
  • XNET N/A
  • RAPP N/A
  • Industry
  • XNET Computer Software: Prepackaged Software
  • RAPP
  • Sector
  • XNET Technology
  • RAPP
  • Exchange
  • XNET Nasdaq
  • RAPP Nasdaq
  • Market Cap
  • XNET 373.0M
  • RAPP 439.4M
  • IPO Year
  • XNET 2014
  • RAPP 2024
  • Fundamental
  • Price
  • XNET $4.55
  • RAPP $14.85
  • Analyst Decision
  • XNET
  • RAPP Strong Buy
  • Analyst Count
  • XNET 0
  • RAPP 2
  • Target Price
  • XNET N/A
  • RAPP $35.00
  • AVG Volume (30 Days)
  • XNET 595.8K
  • RAPP 150.4K
  • Earning Date
  • XNET 08-12-2025
  • RAPP 08-07-2025
  • Dividend Yield
  • XNET N/A
  • RAPP N/A
  • EPS Growth
  • XNET N/A
  • RAPP N/A
  • EPS
  • XNET N/A
  • RAPP N/A
  • Revenue
  • XNET $331,614,000.00
  • RAPP N/A
  • Revenue This Year
  • XNET N/A
  • RAPP N/A
  • Revenue Next Year
  • XNET N/A
  • RAPP N/A
  • P/E Ratio
  • XNET N/A
  • RAPP N/A
  • Revenue Growth
  • XNET N/A
  • RAPP N/A
  • 52 Week Low
  • XNET $1.46
  • RAPP $6.43
  • 52 Week High
  • XNET $7.19
  • RAPP $29.74
  • Technical
  • Relative Strength Index (RSI)
  • XNET 47.39
  • RAPP N/A
  • Support Level
  • XNET $4.41
  • RAPP N/A
  • Resistance Level
  • XNET $4.89
  • RAPP N/A
  • Average True Range (ATR)
  • XNET 0.23
  • RAPP 0.00
  • MACD
  • XNET 0.04
  • RAPP 0.00
  • Stochastic Oscillator
  • XNET 65.17
  • RAPP 0.00

About XNET Xunlei Limited

Xunlei Ltd is a cloud-based acceleration technology company in China. The company operates a powerful internet platform in China based on cloud computing to provide users with quick and easy access to digital media content through its products and services, Xunlei Accelerator, and cloud acceleration subscription services. It is increasingly extending into mobile devices in part through potentially pre-installed acceleration products in mobile phones Xunlei has developed various value-added services to meet a fuller spectrum of its users' digital media content access and consumption needs.

About RAPP Rapport Therapeutics Inc. Common Stock

Rapport Therapeutics Inc is a clinical-stage biopharmaceutical company focused on discovery and development of transformational small-molecule medicines for patients suffering from central nervous system disorders. Its foundational science has elucidated the complexities of neuronal receptor biology and enables the company to map and target certain neuronal receptor complexes. Neuronal receptors are complex assemblies of proteins, comprising receptor principal subunits and their receptor-associated proteins (RAPs), the latter of which play crucial roles in regulating receptor expression and function.

Share on Social Networks: